News
Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...
MADRID and CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), a clinical-stage biopharmaceutical company and a European leader in ...
Public hospitals have negotiated with pharmaceutical companies as part of efforts to bring down operational costs and ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have found a way to do just that—by tweaking a key molecule in the vaccine’s ...
Last week, antivaxxer Toby Rogers published two very long screeds attacking the EBM paradigm. Cleverly, echoed some of our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results